RCM
ACUR

Rotella Capital Management’s Acura Pharmaceuticals ACUR Stock Holding History

Rotella Capital Management’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,195
Closed -$23K – 443
2014
Q1 		$23K Buy
+3,195
New +$27.8K 0.03% 229

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return

Rotella Capital Management's ACUR Position: Q2 2014 in Review

Rotella Capital Management sold out of Acura Pharmaceuticals (ACUR) in Q2 2014, closing a stake of 3,195 shares — an estimated $23K sold.

Rotella Capital Management first reported a position in ACUR in Q1 2014 and held it in 1 quarter. The position peaked at $23K in Q1 2014. 33 funds tracked by Wall St. Rank hold ACUR as of Q2 2014.

  • Rotella Capital Management reported no remaining Acura Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Rotella Capital Management sold 3,195 Acura Pharmaceuticals shares in Q2 2014, an estimated $23K.
  • Rotella Capital Management first reported a position in Acura Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • Rotella Capital Management's Acura Pharmaceuticals position peaked at $23K in Q1 2014.
  • 33 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q2 2014.

Based on Rotella Capital Management's 13F filing for Q2 2014, filed 18 Aug 2014.